November 22, 2026
From Enrollment Moratoria to Rigorous Review The Evolving Landscape of Medicare Oversight for Home Health and Hospice Providers

From Enrollment Moratoria to Rigorous Review The Evolving Landscape of Medicare Oversight for Home Health and Hospice Providers

The Centers for Medicare & Medicaid Services (CMS) is approaching a critical juncture in its ongoing efforts to safeguard the Medicare Trust Fund from fraudulent activities within the home health and hospice sectors. For the past six months, the agency’s primary strategy has relied on a "closed-door" policy—a nationwide moratorium on the enrollment of new hospice and home health agencies, as well as new branch locations and specific ownership changes. This moratorium, which was implemented on May 13 to address a surge in suspicious provider activity, is scheduled to expire on November 13. As the deadline approaches, the healthcare industry is preparing for a transition from broad enrollment freezes to a more surgical, data-driven oversight mechanism: the expansion of claim-by-claim reviews and the Review Choice Demonstration (RCD) program.

While the moratorium served as a necessary emergency brake, CMS officials and industry analysts suggest that the future of oversight lies in persistent, high-intensity auditing of agencies already within the system. This shift represents a move away from preventing new entries and toward a permanent state of heightened scrutiny for existing providers. The implications of this transition are profound, affecting not only the administrative operations of thousands of agencies but also the access to care for some of the nation’s most vulnerable patient populations.

The Success and Limitations of the Enrollment Moratorium

The six-month freeze initiated in May was designed to stem the tide of "shell" agencies and fraudulent startups that had begun to proliferate in specific geographic hotspots. According to senior CMS officials, the moratorium has been an effective, if blunt, instrument. In the first five months of the freeze, approximately 250 home health agencies and 50 hospice providers were denied enrollment nationwide. By preventing these entities from entering the Medicare program, CMS argues it has successfully mitigated the risk of improper billing before it could begin.

However, a moratorium is by nature a temporary measure. It does not distinguish between legitimate entrepreneurs seeking to fill gaps in care and bad actors looking to exploit the system. Furthermore, it does not address the potential for fraud within the thousands of agencies already holding active provider numbers. As the November 13 expiration date nears, CMS appears ready to replace the "closed door" with a "microscope," focusing on the Review Choice Demonstration as its primary tool for long-term integrity.

Expanding the Review Choice Demonstration: The California Expansion

A central component of the new oversight era is the expansion of the Review Choice Demonstration (RCD) for home health services. On November 2, CMS announced plans to extend this program to California, one of the nation’s largest and most complex healthcare markets. Pending final paperwork approval, the program is slated to begin for billing periods starting on or after January 18, 2027.

Under the RCD, California agencies will be required to choose between two primary oversight tracks: pre-claim review or postpayment review. The selection period for these agencies is scheduled to run from November 16 through December 16. If an agency fails to make a proactive choice, it will be placed into the postpayment review track by default.

California will join a growing list of states already under the RCD umbrella, including Illinois, Ohio, Texas, North Carolina, Florida, and Oklahoma. Industry leaders, including representatives from associations like McKnight’s Home Care, have noted that the expansion into California signals CMS’s intent to use RCD as a more sustainable alternative to enrollment moratoria. By requiring agencies to prove the validity of their claims in real-time or near-real-time, CMS aims to foster a culture of compliance that outlasts temporary freezes.

Hospice Oversight and the OIG’s Financial Projections

The hospice sector is facing a similar trajectory toward intensified review. In June, the Department of Health and Human Services (HHS) Office of Inspector General (OIG) released a report estimating that Medicare could have saved approximately $255.1 million in hospice services related to certain new enrollees if stricter oversight had been in place.

The OIG’s findings were based on a sample of 100 initial certification periods. The results were startling: 45% of the sampled claims did not meet Medicare requirements. Specifically, 21 cases lacked sufficient clinical support to justify a terminal prognosis, while 24 cases suffered from significant documentation errors. These findings led the OIG to recommend that Medicare contractors implement either prepayment or postpayment reviews for new hospice enrollees—a recommendation that CMS has formally accepted.

This data underscores the reality that "bad" claims are often the result of two distinct issues: intentional fraud (greed) and administrative incompetence (rushing to market). Regardless of the intent, the financial impact on the Medicare program is the same, necessitating a more rigorous approach to documentation and clinical justification.

Analyzing the Friction: Affirmations, Denials, and Appeals

CMS data for fiscal year 2024 provides a nuanced look at how the Review Choice Demonstration operates in practice. On the surface, the program appears to reward high-performing agencies. In states currently participating in the demonstration, 97% of home health pre-claim review requests were affirmed. Agencies that maintain an affirmation rate of 90% or higher are granted "relief" from the majority of reviews, subjected only to occasional spot checks.

However, the data also reveals significant friction within the system. For claims that underwent standard prepayment or postpayment review, the approval rate dropped to 84.4%. Even more telling is the appeals process: of the claims that were denied and subsequently appealed, 51.6% were overturned at the first level of review.

According to CMS, these reversals most often occur because providers finally submit the necessary documentation—such as physician signatures or face-to-face encounter notes—that was missing during the initial review. This 51.6% reversal rate highlights a massive administrative inefficiency. It suggests that more than half of contested denials could be avoided if expectations were clearer and documentation were more thorough from the outset. For small agencies with limited administrative staff, the hours spent chasing missing signatures to win an appeal represent a significant drain on resources that could otherwise be directed toward patient care.

The Uneven Burden of Compliance

While oversight is universally recognized as necessary to combat fraud, the burden of expanded review does not fall evenly across the industry. Large health systems and national provider chains typically possess the infrastructure—legal teams, compliance officers, and sophisticated electronic health record (EHR) systems—to absorb the costs of rigorous auditing and the appeals process.

In contrast, small, independent agencies often operate on thin margins with minimal office support. For these providers, a stack of claim denials or a sudden slowdown in cash flow caused by pre-claim review delays can be catastrophic. There is a growing concern among industry advocates that excessive "administrative friction" could lead smaller, high-quality providers to close their doors or become overly cautious about admitting complex, high-needs patients. If this occurs, the very patients the Medicare program is designed to protect may find themselves with fewer options for home-based care.

Recommendations for a Fairer Oversight Framework

To ensure that expanded review effectively targets bad actors without dismantling the provider network, several policy adjustments have been proposed by industry experts and legal analysts:

  1. Centralized Documentation Standards: CMS should provide a single, easily accessible repository of documentation standards. Currently, providers must often navigate various contractor-specific interpretations of what constitutes "homebound status" or "terminal prognosis." Clear, unified expectations would reduce the "guesswork" that leads to initial denials.
  2. Publicity of Educational Lessons: While Medicare contractors currently offer education to agencies following non-affirmations, these lessons are often private. Making the top reasons for denials public—broken down by state and contractor—would allow all agencies to learn from common mistakes and improve their submissions proactively.
  3. Access Metrics: Integrity and access must be measured side-by-side. As RCD and hospice reviews expand, CMS should track and report on patient access metrics, such as the time it takes for a patient to be admitted to home health or hospice following a referral. If oversight is causing significant delays in care, the program may need adjustment.
  4. Pattern Recognition: CMS should use its yearly statistics to identify whether problems cluster around specific documentation elements or specific contractors. This would help determine if certain reviewers are being overly aggressive or if a particular regulation is consistently misunderstood by the provider community.

Preparing for the Post-Moratorium Era

As the enrollment moratorium expires on November 13, the message to home health and hospice owners is clear: compliance is no longer a periodic check-up; it is a core operational requirement. Legal experts recommend that agencies move compliance out of the "annual binder" and into weekly Key Performance Indicator (KPI) meetings.

Agencies are encouraged to maintain internal logs of every review request and decision, allowing them to identify their own patterns of error before a federal contractor does. By treating prior authorization and pre-claim reviews as a "free pre-audit," agencies can use the feedback to harden their internal policies.

The window for public input on the California expansion remains open only until November 16. As the industry shifts from the blunt tool of enrollment freezes to the refined tool of constant review, the feedback from providers will be essential in shaping a system that protects the taxpayer without compromising the delivery of essential home-based healthcare. The headlines may focus on the "closed doors" of the moratorium, but the "quiet rules" of claim review will define the future of the industry for years to come.

Leave a Reply

Your email address will not be published. Required fields are marked *